Inventor · disambiguated record
Christoph Schumacher
Also filed as: SCHUMACHER CHRISTOPH
14 granted patents·14 pending applications·36 citations·filing 2005–2024
89Inventor score
Top patents by PatentIndex Score
28 records- 0193US11447491B2Aldosterone synthase inhibitorDAMIAN PHARMA AG·Filed 2020·Granted Sep 20, 2022·3 cites·28 claims
- 0291US10822332B2Aldosterone synthase inhibitorDAMIAN PHARMA AG·Filed 2017·Granted Nov 3, 2020·5 cites·17 claims
- 0390US8609862B2Use of an adrenal hormone-modifying agentHU QI-YING·Filed 2011·Granted Dec 17, 2013·8 cites·5 claims
- 0484US8071773B2Heterocyclic spiro-compounds as aldosterone synthase inhibitorsHEROLD PETER·Filed 2006·Granted Dec 6, 2011·9 cites·6 claims
- 0584US2025129071A1Aldosterone synthase inhibitorDAMIAN PHARMA AG·Filed 2024·Application pending·0 cites
- 0683US7612088B2Heterocyclic compounds and their use as aldosterone synthase inhibitorsSPEEDEL EXPERIMENTA AG·Filed 2005·Granted Nov 3, 2009·7 cites·11 claims
- 0780US12202827B2Aldosterone synthase inhibitorDAMIAN PHARMA AG·Filed 2022·Granted Jan 21, 2025·0 cites·24 claims
- 0871US8680079B2Tetrahydro-imidazo [1,5-A] pyridyin derivatives as aldosterone synthase inhibitorsHEROLD PETER·Filed 2005·Granted Mar 25, 2014·1 cites·16 claims
- 0971US2024269119A1R-fadrozole for use in the treatment of aldostonerismDAMIAN PHARMA AG·Filed 2024·Application pending·0 cites
- 1069US9517226B2Inhibitors for treating diseases characterized by atrial enlargement or remodelingSCHUMACHER CHRISTOPH·Filed 2013·Granted Dec 13, 2016·3 cites·10 claims
- 1167US9434754B2Use of an adrenal hormone-modifying agentHU QI-YING·Filed 2013·Granted Sep 6, 2016·0 cites·1 claims
- 1264US11135192B2Inhibitors for treating diseases characterized by atrial enlargement or remodelingNOVARTIS AG·Filed 2018·Granted Oct 5, 2021·0 cites·6 claims
- 1360US9937143B2Inhibitors for treating diseases characterized by atrial enlargement or remodelingNOVARTIS AG·Filed 2016·Granted Apr 10, 2018·0 cites·8 claims
- 1460US2010029694A1Heterocyclic compounds and their use as aldosterone synthase inhibitorsHEROLD PETER·Filed 2009·Application pending·0 cites
- 1557US11992479B2R-fadrozole for use in the treatment of aldostonerismDAMIAN PHARMA AG·Filed 2019·Granted May 28, 2024·0 cites·18 claims
- 1654US2007021400A1Amino alcohols as therapeutic compoundsHEROLD PETER·Filed 2006·Application pending·0 cites
- 1753US10549021B2Peristaltic pump and pumping method, in particular for use as implantETH ZUERICH·Filed 2014·Granted Feb 4, 2020·0 cites·16 claims
- 1846US2009325947A1Nitrate esters of piperidinesHEROLD PETER·Filed 2007·Application pending·0 cites
- 1945US2007167433A13,4,5-Substituted piperidines as therapeutic compoundsHEROLD PETER·Filed 2007·Application pending·0 cites
- 2044US8071774B2Heterocyclic spiro-compounds as aldosterone synthase inhibitorsHEROLD PETER·Filed 2006·Granted Dec 6, 2011·0 cites·9 claims
- 2143US2007021413A1Diamino alcohols as therapeutic compoundsHEROLD PETER·Filed 2006·Application pending·0 cites
- 2243US2007066604A1Diaminoalcohols as therapeutic compoundsHEROLD PETER·Filed 2006·Application pending·0 cites
- 2343US2007066582A1Diaminoalcohols as therapeutic compoundsHEROLD PETER·Filed 2006·Application pending·0 cites
- 2443US2007021399A1Amido-amino alcohols as therapeutic compoundsHEROLD PETER·Filed 2006·Application pending·0 cites
- 2542US2010168145A1Fused imidazole derivatives and use thereof as aldosterone synthase inhibitorsSPEEDEL EXPERIMENTA AG·Filed 2006·Application pending·0 cites
- 2641US2008076794A1Heterocyclic Compounds And Their Use As Aldosterone Synthase InhibitorsHEROLD PETER·Filed 2005·Application pending·0 cites
- 2740US2010173919A1Pharmaceutical composition using aliskiren and avosentanSCHUMACHER CHRISTOPH·Filed 2007·Application pending·0 cites
- 2835US2010160358A1Pyridylsulfonamidyl-Pyrimidines for the Prevention of Blood Vessel Graft FailureSCHUMACHER CHRISTOPH·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christoph Schumacher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →